Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

A groundbreaking study reveals that concussions and repetitive head injuries in sports could trigger latent viruses in the ...

Researchers believe a simple blood test could flag people who are in the early stages of Alzheimer's, as well as spotting ...

The study reveals a potential link between concussions and the activation of dormant viruses, which may lead to ...

Naturally, more work is needed. Although GLS -1 agonists have been used in diabetes for 20 years, some of the newer findings ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the low probability of success.

Plus: A startup bioengineering off-the-shelf arteries, how viruses may cause Alzheimer’s, water-powered satellites and more.

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

D imaging and organoid models are revolutionizing dementia research, offering deeper insights into disease mechanisms and ...